Apple: results out on Tuesday. Photograph: Josh Edelson/AFP/Getty Images
For your diary

TODAY Results: TNT Express. Indicators: Irish retail sales (Sept); German IFO business climate (Oct); US Dallas Fed manufacturing index (Oct); US new (...)

Under Hillary Clinton’s plan, the $250 monthly cap would limit what insurance companies could ask patients to pay for drugs that treat patients with chronic or serious medical conditions. Photograph: CBS News/Reuters

US Democrat presidential candidate Hillary Clinton on Tuesday will propose a $250 (€225) monthly cap on prescription drugs to stop what she calls “exc(...)

Sales of Gilead Sciences’ drugs to treat hepatitis C reached $4.55 billion in the first quarter, far exceeding already lofty Wall Street expectations(...)

Bood day, bad day: Aer Lingus rose on the Iseq while CRH and Ryanair fell. Photograph: Alan Betson

European stocks declined on Monday after last week’s gains, but the FTSE 100 blue-chip index managed to reverse slips in early trading to set a new r(...)

An automated machine works on purification of  hepatitis C virus drug. Photographer: David Paul Morris/Bloomberg

Gilead Sciences, whose $1,000-a-pill hepatitis C treatment is one of the world’s most expensive drugs, is avoiding billions of dollars in US taxes by (...)

Express Scripts, which will no longer offer Harvoni, manages pharmacy benefits for about 85 million people in the US

Gilead Sciences may finally be forced to offer a lower price for its $94,500 hepatitis C drug. The biotechnology company could have no choice but to n(...)

In London Marks & Spencer lost 3 per cent amid signs that the retailer’s recently overhauled online service has been struggling to cope with Christmas demand

The latest signs of weakness from the Chinese economy spooked investors during a dismal start to the week for European markets.Mining stocks came und(...)

Total spending on drugs will hit $1.06 trillion this year, an increase of 7 per cent over 2013 levels

Pharmaceutical spending will break the trillion dollar mark in 2014, driven by high prices in the United States for novel treatments such as Gilead Sc(...)

Gilead Sciences will allow seven large Indian generic drug producers to make and sell its blockbuster hepatitis C drug Sovaldi in more than 90 develop(...)

Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and hosts lavish parties for (...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next
  • Last »